Clinical Trials Logo

Stool Microbiome clinical trials

View clinical trials related to Stool Microbiome.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05304715 Completed - Mortality Clinical Trials

Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection

BEYOND
Start date: April 13, 2022
Phase: Phase 2
Study type: Interventional

Previous data have shown that integrated information from single nucleotide polymorphisms (SNPs) of the host DNA, interleukin 8 (IL-8) and the enrichment of the stool microbiome can indicate the patients with infection by Clostridioides difficile (CDI) who are at risk for unfavorable outcome. This integrated information is forming the BEYOND score. The aim of the BEYOND randomized clinical trial (RCT) is to investigate if adjunctive bezlotoxumab treatment to the current standard-of-care may decrease the likelihood of unfavorable outcome for patients who score positive by the BEYOND score.

NCT ID: NCT04264923 Completed - Stool Microbiome Clinical Trials

Evaluation of Stool Microbiome Using HyGIeaCare Prep

Start date: June 27, 2019
Phase: N/A
Study type: Interventional

Stool samples will be collected before and during the HyGIeaCare procedure and the samples will be sent for microbiome evaluation.

NCT ID: NCT03477825 Completed - Wrinkles Clinical Trials

Pilot Study of Triphala and Rubia Cordifolia on Gut Microbiome and Skin

Start date: March 12, 2018
Phase: N/A
Study type: Interventional

Few studies have assessed the effects of Triphala and Rubia Cordifolia from a skin biophysical perspective. Here, we aim to understand how these herbs can modulate the skin's barrier properties and the gut microbiome.